Global Connected Drug Delivery Devices Market (2018-2025)-GMI Research

Factors such as the growing incidence of chronic disease, increasing geriatric population and rising preference for connected injectable drug delivery are driving the growth of global connected drug delivery device market during the forecast period.
 
 
Global Connected Drug Delivery Devices Market
Global Connected Drug Delivery Devices Market
 
Spread the Word
Listed Under

Tag:
* GMI Research

Industry:
* Reports

Location:
* Dublin - Dublin - Ireland

Subject:
* Reports

DUBLIN - Nov. 26, 2018 - PRLog -- Global Connected Drug Delivery Devices Market by Product Type (Inhalation Devices, Solid Dosage Forms Devices and Injectable Devices), By Technology (Bluetooth, Near Field Communication and Others), By End-Users (Hospitals, Ambulatory Surgical Centers and Homecare Settings) and by Geography – Opportunities & Forecast, 2018-2025

Connected drug delivery devices are widely used among healthcare professionals as well as patients.  Connected drug delivery devices are designed in a way to accomplish a multifunctional task as it helps to record and remind dossing pattern, addressing the issues related to the medication management, etc. Connected drug delivery devices are basically user-friendly, patient-centric, quick and efficient, easily accessible. The deployment of connected drug delivery devices is gaining traction across the globe.

Factors such as the growing incidence of chronic disease, increasing geriatric population and rising preference for connected injectable drug delivery are driving the growth of global connected drug delivery device market during the forecast period. In addition, cloud-based computing models, the proliferation of mobile health application, introduction of the monitoring device and advancement in healthcare IT are leading the healthcare industry towards the new era. Moreover, increase use of self-administration of drugs through connected drug delivery device and penetration of artificial intelligence technology and big data analytics, especially for real-time decision making to manage medication is expected to fuel the growth of the market. One of the key challenges for widespread adoption in connected drug delivery applications remains the integration of electronic communications systems into the devices. However, cost containment, inadequate reimbursement policies in emerging countries and lack of awareness among patient regarding the latest technology are the major factors that are restraining  the growth of global connected drug delivery devices market over the coming few years.

Various notable players operating in the market, include Phillips-Medisize, West Pharmaceutical Service, Biocorp Production SA, Aterica, Unilife Corporation,     Panasonic, Propeller Health, Qualcomm Technologies, Bayer AG, 3M Company among others. Most of the pharmaceutical company are focusing on strategic collaboration with tech firms to design and developed innovative product. For instance, Propeller Health entered into a strategic partnership with Express Scripts to provide digital solutions to Express Script members.

The global connected drug delivery devices market has been segmented on the basis of product type, technology, end-users, and key geographies. Based on product type, the market comprises of inhalation devices, solid dosage forms devices and injectable device. The research report "global connected drug delivery devices market" provides in-depth analysis of global connected drug delivery devices market based on product type, technology, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global connected drug delivery devices market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is connected drug delivery devices market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the connected drug delivery devices market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation

By Product Type
•    Inhalation Devices
•    Solid Dosage Forms Devices
•    Injectable Devices
o    Handheld Injectable Devices
o    Wearable Injectable Devices

By Technology
•    Bluetooth
•    Near Field Communication
•    Others

By End-Users
•    Hospitals
•    Ambulatory Surgical Centers
•    Homecare Settings

By Geography

•    North America
As a part of customization
o    By Product Type
o    By Technology
o    By End users
o    US
o    Canada
o    Mexico

•    Europe
As a part of customization
o    By Product Type
o    By Technology
o    By End users
o    UK
o    Germany
o    Spain
o    Rest of Europe

•    Asia-Pacific
As a part of customization
o    By Product Type
o    By Technology
o    By End users
o    China
o    Australia
o    India
o    Rest of APAC

•    ROW
As a part of customization
o    By Product Type
o    By Technology
o    By End users
o    Brazil
o    South Africa
o    GCC countries
o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    Phillips-Medisize;
•    West Pharmaceutical Service
•    Biocorp Production SA
•    Aterica
•    Unilife Corporation
•    Panasonic
•    Propeller Health
•    Qualcomm Technologies
•    Bayer AG
•    3M Company

*Other prominent players in the market which can be profiled as a part of customization:
CeQurSA
CareTRx
CoheroHealth
Teva Pharmaceutical Industries Ltd

For Sample Pages & Detailed Report Description Visit : https://www.gmiresearch.com/report/global-connected-drug-...

Contact
Sarah Nash
sales@gmiresearch.com
+1 860 881 2270
End
Email:***@gmiresearch.com
Posted By:***@gmiresearch.com Email Verified
Tags:GMI Research
Industry:Reports
Location:Dublin - Dublin - Ireland
Subject:Reports
Account Email Address Verified     Disclaimer     Report Abuse
GMI Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share